A new report from IbisWorld foresees a positive outlook for nebulizer sales after estimated annualized growth rate of 6.2% from 2007 to 2012. The report suggests that an aging population and increasing diagnoses of respiratory illnesses, plus an improving economy will help manufacturers to overcome “some market saturation and new federal regulations.” Total revenue for 2012 is estimated at $208 million.
A “report snapshot” on the company website lists the number of nebulizer manufacturing companies at 20, with a total of 668 employees, and acknowledges that PARI and Phillips dominate the industry. The report also estimates wages at 24% of revenue, noting that “The industry requires skilled specialists for research and development (R&D), and these employees command salaries well above the manufacturing sector average wage.”
Read the IbisWorld press release.
